Paris-based HealthTech company Hublo has received a €40M reinvestment from growth investor Revaia, extending the partnership beyond its original investment cycle and backing the company through its next stage of expansion.
The reinvestment follows the strategic transaction in 2025 and comes shortly after Revaia closed its €250M Growth II fund. Rather than exiting fully, Revaia has created a dedicated reinvestment vehicle, allowing both existing and new investors from Europe, the UK, and the US to continue supporting Hublo alongside its new majority shareholder.
Antoine Loron, co-founder and co-CEO, said the move reflects long-term alignment between the company and its investors. According to Loron, Revaia’s decision to reinvest strengthens Hublo’s shareholder base and provides stability as the company enters its next development phase.
Built during crisis, scaled for resilience
Founded in 2016, the company emerged from the merger of Whoog and MedGo during the Covid crisis, responding to chronic staffing shortages across healthcare systems. The platform enables hospitals and care facilities to manage recruitment, shift scheduling, internal mobility, and staff communication within a single system.
By 2025, Hublo was used by more than 22,000 managers across 5,000 healthcare facilities, supporting close to 1 million healthcare professionals. The company reports that users save an average of 2.5 hours per day through improved workforce coordination.
Revaia first acquired a significant stake in Hublo in 2021 and supported its scaling phase, during which the company quadrupled its annual recurring revenue and reached operational break-even ahead of plan.
Advertisement
From Growth I exit to continued conviction
In July 2025, Five Arrows, the alternative investment arm of Rothschild & Co, completed a strategic investment in Hublo following a competitive process. This transaction marked the first exit from Revaia’s Growth I fund.
Rather than stepping away, Revaia chose to deepen its involvement through the new reinvestment structure. Founding Partner Alice Albizzati said the vehicle reflects strong confidence in both the management team and the firm’s long-term trajectory, while also opening the door for new investors to participate in the next phase of value creation.
About Hublo
Hublo develops workforce management software for healthcare organisations, covering recruitment, staffing, scheduling, and internal mobility. Its technology is designed to improve working conditions for healthcare professionals, increase operational efficiency, and help care providers deliver high-quality patient care through smarter, more flexible workforce management.
